{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "11673-100",
      "generic_name": "Glycerin, Naphazoline hydrochloride",
      "labeler_name": "Target Corporation",
      "brand_name": "Target Eye Drops Maximum Redness Relief Eye",
      "active_ingredients": [
        {
          "name": "GLYCERIN",
          "strength": "500 mg/100mL"
        },
        {
          "name": "NAPHAZOLINE HYDROCHLORIDE",
          "strength": "30 mg/100mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "11673-100-01",
          "description": "1 BOTTLE, DROPPER in 1 BOX (11673-100-01)  / 15 mL in 1 BOTTLE, DROPPER",
          "marketing_start_date": "20190208",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Target Corporation"
        ],
        "rxcui": [
          "1235200"
        ],
        "spl_set_id": [
          "1b26cd3b-4a05-4623-b320-01f22b3106ff"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000185370",
          "N0000175629",
          "N0000184306",
          "N0000185001",
          "M0000728",
          "M0009417"
        ],
        "pharm_class_epc": [
          "Non-Standardized Chemical Allergen [EPC]"
        ],
        "pharm_class_pe": [
          "Increased Histamine Release [PE]",
          "Cell-mediated Immunity [PE]",
          "Increased IgG Production [PE]"
        ],
        "pharm_class_cs": [
          "Allergens [CS]",
          "Glycerol [CS]"
        ],
        "unii": [
          "PDC6A3C0OX",
          "MZ1131787D"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SOLUTION/ DROPS",
      "spl_id": "0cfa0b71-d377-fa73-e063-6294a90a390e",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "OPHTHALMIC"
      ],
      "marketing_start_date": "20190208",
      "product_id": "11673-100_0cfa0b71-d377-fa73-e063-6294a90a390e",
      "application_number": "M018",
      "brand_name_base": "Target Eye Drops Maximum Redness Relief Eye",
      "pharm_class": [
        "Allergens [CS]",
        "Cell-mediated Immunity [PE]",
        "Glycerol [CS]",
        "Increased Histamine Release [PE]",
        "Increased IgG Production [PE]",
        "Non-Standardized Chemical Allergen [EPC]"
      ]
    }
  ]
}